Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Peptide Therapeutics Market 2018, Forecast to 2023

August 2018 | 147 pages | ID: GB2BC7BC991EN
GlobalInfoResearch

Abstracts

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

In this report, we study the peptide-based drugs.

Scope of the Report:

This report focuses on the Peptide Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
The worldwide market for Peptide Therapeutics is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 39300 million US$ in 2023, from 28500 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Sanofi
• Teva
• Novo Nordisk
• Takeda
• Eli Lilly
• AstraZeneca
• Novartis
• Shire
• AbbVie
• Ipsen
• Allergan
• Ferring
• Merck
• The Medicines
• Roche
• J & J

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Injection
• Oral
• Other

Market Segment by Applications, can be divided into

• Cancer
• Metabolic Disorders
• Central Nervous System
• Other

There are 15 Chapters to deeply display the global Peptide Therapeutics market.
Chapter 1, to describe Peptide Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Peptide Therapeutics, with sales, revenue, and price of Peptide Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Peptide Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Peptide Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Peptide Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Peptide Therapeutics Introduction
1.2 Market Analysis by Type
  1.2.1 Injection
  1.2.2 Oral
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 Cancer
  1.3.2 Metabolic Disorders
  1.3.3 Central Nervous System
  1.3.4 Other
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Sanofi
  2.1.1 Business Overview
    2.1.1.1 Sanofi Description
    2.1.1.2 Sanofi Headquarter, Main Business and Finance Overview
  2.1.2 Sanofi Peptide Therapeutics Product Introduction
    2.1.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Peptide Therapeutics Product Information
  2.1.3 Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Sanofi Peptide Therapeutics Market Share in 2017
2.2 Teva
  2.2.1 Business Overview
    2.2.1.1 Teva Description
    2.2.1.2 Teva Headquarter, Main Business and Finance Overview
  2.2.2 Teva Peptide Therapeutics Product Introduction
    2.2.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Peptide Therapeutics Product Information
  2.2.3 Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Teva Peptide Therapeutics Market Share in 2017
2.3 Novo Nordisk
  2.3.1 Business Overview
    2.3.1.1 Novo Nordisk Description
    2.3.1.2 Novo Nordisk Headquarter, Main Business and Finance Overview
  2.3.2 Novo Nordisk Peptide Therapeutics Product Introduction
    2.3.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Peptide Therapeutics Product Information
  2.3.3 Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Novo Nordisk Peptide Therapeutics Market Share in 2017
2.4 Takeda
  2.4.1 Business Overview
    2.4.1.1 Takeda Description
    2.4.1.2 Takeda Headquarter, Main Business and Finance Overview
  2.4.2 Takeda Peptide Therapeutics Product Introduction
    2.4.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Peptide Therapeutics Product Information
  2.4.3 Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Takeda Peptide Therapeutics Market Share in 2017
2.5 Eli Lilly
  2.5.1 Business Overview
    2.5.1.1 Eli Lilly Description
    2.5.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
  2.5.2 Eli Lilly Peptide Therapeutics Product Introduction
    2.5.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Peptide Therapeutics Product Information
  2.5.3 Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Eli Lilly Peptide Therapeutics Market Share in 2017
2.6 AstraZeneca
  2.6.1 Business Overview
    2.6.1.1 AstraZeneca Description
    2.6.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
  2.6.2 AstraZeneca Peptide Therapeutics Product Introduction
    2.6.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Peptide Therapeutics Product Information
  2.6.3 AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global AstraZeneca Peptide Therapeutics Market Share in 2017
2.7 Novartis
  2.7.1 Business Overview
    2.7.1.1 Novartis Description
    2.7.1.2 Novartis Headquarter, Main Business and Finance Overview
  2.7.2 Novartis Peptide Therapeutics Product Introduction
    2.7.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Peptide Therapeutics Product Information
  2.7.3 Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Novartis Peptide Therapeutics Market Share in 2017
2.8 Shire
  2.8.1 Business Overview
    2.8.1.1 Shire Description
    2.8.1.2 Shire Headquarter, Main Business and Finance Overview
  2.8.2 Shire Peptide Therapeutics Product Introduction
    2.8.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Peptide Therapeutics Product Information
  2.8.3 Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global Shire Peptide Therapeutics Market Share in 2017
2.9 AbbVie
  2.9.1 Business Overview
    2.9.1.1 AbbVie Description
    2.9.1.2 AbbVie Headquarter, Main Business and Finance Overview
  2.9.2 AbbVie Peptide Therapeutics Product Introduction
    2.9.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Peptide Therapeutics Product Information
  2.9.3 AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global AbbVie Peptide Therapeutics Market Share in 2017
2.10 Ipsen
  2.10.1 Business Overview
    2.10.1.1 Ipsen Description
    2.10.1.2 Ipsen Headquarter, Main Business and Finance Overview
  2.10.2 Ipsen Peptide Therapeutics Product Introduction
    2.10.2.1 Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Peptide Therapeutics Product Information
  2.10.3 Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Ipsen Peptide Therapeutics Market Share in 2017
2.11 Allergan
  2.11.1 Business Overview
  2.11.2 Allergan Peptide Therapeutics Product Introduction
  2.11.3 Allergan Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ferring
  2.12.1 Business Overview
  2.12.2 Ferring Peptide Therapeutics Product Introduction
  2.12.3 Ferring Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Merck
  2.13.1 Business Overview
  2.13.2 Merck Peptide Therapeutics Product Introduction
  2.13.3 Merck Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 The Medicines
  2.14.1 Business Overview
  2.14.2 The Medicines Peptide Therapeutics Product Introduction
  2.14.3 The Medicines Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche
  2.15.1 Business Overview
  2.15.2 Roche Peptide Therapeutics Product Introduction
  2.15.3 Roche Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 J & J
  2.16.1 Business Overview
  2.16.2 J & J Peptide Therapeutics Product Introduction
  2.16.3 J & J Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PEPTIDE THERAPEUTICS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Peptide Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Peptide Therapeutics Manufacturer Market Share in 2017
  3.4.2 Top 5 Peptide Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL PEPTIDE THERAPEUTICS MARKET ANALYSIS BY REGIONS

4.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Regions
  4.1.1 Global Peptide Therapeutics Sales by Regions (2013-2018)
  4.1.2 Global Peptide Therapeutics Revenue by Regions (2013-2018)
4.2 North America Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA PEPTIDE THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Peptide Therapeutics Sales, Revenue and Market Share by Countries
  5.1.1 North America Peptide Therapeutics Sales by Countries (2013-2018)
  5.1.2 North America Peptide Therapeutics Revenue by Countries (2013-2018)
  5.1.3 United States Peptide Therapeutics Sales and Growth Rate (2013-2018)
  5.1.4 Canada Peptide Therapeutics Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Peptide Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Peptide Therapeutics Sales by Manufacturers (2016-2017)
  5.2.2 North America Peptide Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)

6 EUROPE PEPTIDE THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Peptide Therapeutics Sales, Revenue and Market Share by Countries
  6.1.1 Europe Peptide Therapeutics Sales by Countries (2013-2018)
  6.1.2 Europe Peptide Therapeutics Revenue by Countries (2013-2018)
  6.1.3 Germany Peptide Therapeutics Sales and Growth Rate (2013-2018)
  6.1.4 UK Peptide Therapeutics Sales and Growth Rate (2013-2018)
  6.1.5 France Peptide Therapeutics Sales and Growth Rate (2013-2018)
  6.1.6 Russia Peptide Therapeutics Sales and Growth Rate (2013-2018)
  6.1.7 Italy Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Peptide Therapeutics Sales by Manufacturers (2016-2017)
  6.2.2 Europe Peptide Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC PEPTIDE THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Peptide Therapeutics Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Peptide Therapeutics Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Peptide Therapeutics Revenue by Countries (2013-2018)
  7.1.3 China Peptide Therapeutics Sales and Growth Rate (2013-2018)
  7.1.4 Japan Peptide Therapeutics Sales and Growth Rate (2013-2018)
  7.1.5 Korea Peptide Therapeutics Sales and Growth Rate (2013-2018)
  7.1.6 India Peptide Therapeutics Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Peptide Therapeutics Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Peptide Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA PEPTIDE THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Peptide Therapeutics Sales, Revenue and Market Share by Countries
  8.1.1 South America Peptide Therapeutics Sales by Countries (2013-2018)
  8.1.2 South America Peptide Therapeutics Revenue by Countries (2013-2018)
  8.1.3 Brazil Peptide Therapeutics Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Peptide Therapeutics Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Peptide Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Peptide Therapeutics Sales by Manufacturers (2016-2017)
  8.2.2 South America Peptide Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA PEPTIDE THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Peptide Therapeutics Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Peptide Therapeutics Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Peptide Therapeutics Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Peptide Therapeutics Sales and Growth Rate (2013-2018)
  9.1.4 UAE Peptide Therapeutics Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Peptide Therapeutics Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Peptide Therapeutics Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Peptide Therapeutics Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Peptide Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL PEPTIDE THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Peptide Therapeutics Sales and Market Share by Type (2013-2018)
  10.1.2 Global Peptide Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Injection Sales Growth and Price
  10.2.1 Global Injection Sales Growth (2013-2018)
  10.2.2 Global Injection Price (2013-2018)
10.3 Oral Sales Growth and Price
  10.3.1 Global Oral Sales Growth (2013-2018)
  10.3.2 Global Oral Price (2013-2018)
10.4 Other Sales Growth and Price
  10.4.1 Global Other Sales Growth (2013-2018)
  10.4.2 Global Other Price (2013-2018)

11 GLOBAL PEPTIDE THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Peptide Therapeutics Sales Market Share by Application (2013-2018)
11.2 Cancer Sales Growth (2013-2018)
11.3 Metabolic Disorders Sales Growth (2013-2018)
11.4 Central Nervous System Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)

12 PEPTIDE THERAPEUTICS MARKET FORECAST (2018-2023)

12.1 Global Peptide Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Peptide Therapeutics Market Forecast by Regions (2018-2023)
  12.2.1 North America Peptide Therapeutics Market Forecast (2018-2023)
  12.2.2 Europe Peptide Therapeutics Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Peptide Therapeutics Market Forecast (2018-2023)
  12.2.4 South America Peptide Therapeutics Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Peptide Therapeutics Market Forecast (2018-2023)
12.3 Peptide Therapeutics Market Forecast by Type (2018-2023)
  12.3.1 Global Peptide Therapeutics Sales Forecast by Type (2018-2023)
  12.3.2 Global Peptide Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Peptide Therapeutics Market Forecast by Application (2018-2023)
  12.4.1 Global Peptide Therapeutics Sales Forecast by Application (2018-2023)
  12.4.2 Global Peptide Therapeutics Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Peptide Therapeutics Picture
Table Product Specifications of Peptide Therapeutics
Figure Global Peptide Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Peptide Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Peptide Therapeutics by Types in 2017
Figure Injection Picture
Table Major Manufacturers of Injection
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Other Picture
Table Major Manufacturers of Other
Figure Peptide Therapeutics Sales Market Share by Applications in 2017
Figure Cancer Picture
Figure Metabolic Disorders Picture
Figure Central Nervous System Picture
Figure Other Picture
Figure United States Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Peptide Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table Sanofi Peptide Therapeutics Product
Table Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Peptide Therapeutics Sales Market Share in 2017
Figure Global Sanofi Peptide Therapeutics Revenue Market Share in 2017
Table Teva Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table Teva Peptide Therapeutics Product
Table Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Peptide Therapeutics Sales Market Share in 2017
Figure Global Teva Peptide Therapeutics Revenue Market Share in 2017
Table Novo Nordisk Headquarter, Established, Main Business and Finance Overview (2017)
Table Novo Nordisk Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table Novo Nordisk Peptide Therapeutics Product
Table Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novo Nordisk Peptide Therapeutics Sales Market Share in 2017
Figure Global Novo Nordisk Peptide Therapeutics Revenue Market Share in 2017
Table Takeda Headquarter, Established, Main Business and Finance Overview (2017)
Table Takeda Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table Takeda Peptide Therapeutics Product
Table Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Takeda Peptide Therapeutics Sales Market Share in 2017
Figure Global Takeda Peptide Therapeutics Revenue Market Share in 2017
Table Eli Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table Eli Lilly Peptide Therapeutics Product
Table Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly Peptide Therapeutics Sales Market Share in 2017
Figure Global Eli Lilly Peptide Therapeutics Revenue Market Share in 2017
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Peptide Therapeutics Product
Table AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Peptide Therapeutics Sales Market Share in 2017
Figure Global AstraZeneca Peptide Therapeutics Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table Novartis Peptide Therapeutics Product
Table Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Peptide Therapeutics Sales Market Share in 2017
Figure Global Novartis Peptide Therapeutics Revenue Market Share in 2017
Table Shire Headquarter, Established, Main Business and Finance Overview (2017)
Table Shire Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table Shire Peptide Therapeutics Product
Table Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Shire Peptide Therapeutics Sales Market Share in 2017
Figure Global Shire Peptide Therapeutics Revenue Market Share in 2017
Table AbbVie Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table AbbVie Peptide Therapeutics Product
Table AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie Peptide Therapeutics Sales Market Share in 2017
Figure Global AbbVie Peptide Therapeutics Revenue Market Share in 2017
Table Ipsen Headquarter, Established, Main Business and Finance Overview (2017)
Table Ipsen Peptide Therapeutics Production Bases, Sales Regions and Major Competitors
Table Ipsen Peptide Therapeutics Product
Table Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ipsen Peptide Therapeutics Sales Market Share in 2017
Figure Global Ipsen Peptide Therapeutics Revenue Market Share in 2017
Table Allergan
Table Allergan Peptide Therapeutics
Table Ferring
Table Ferring Peptide Therapeutics
Table Merck
Table Merck Peptide Therapeutics
Table The Medicines
Table The Medicines Peptide Therapeutics
Table Roche
Table Roche Peptide Therapeutics
Table J & J
Table J & J Peptide Therapeutics
Table Global Peptide Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table Global Peptide Therapeutics Price by Manufacturer (2016-2017)
Figure Top 3 Peptide Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Peptide Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Peptide Therapeutics Sales by Regions (2013-2018)
Table Global Peptide Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Peptide Therapeutics Revenue by Regions (2013-2018)
Figure Global Peptide Therapeutics Revenue Market Share by Regions in 2013
Figure Global Peptide Therapeutics Revenue Market Share by Regions in 2017
Figure North America Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Figure North America Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Peptide Therapeutics Sales by Countries (2013-2018)
Table North America Peptide Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Peptide Therapeutics Sales Market Share by Countries in 2013
Figure North America Peptide Therapeutics Sales Market Share by Countries in 2017
Table North America Peptide Therapeutics Revenue by Countries (2013-2018)
Table North America Peptide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Peptide Therapeutics Revenue Market Share by Countries in 2013
Figure North America Peptide Therapeutics Revenue Market Share by Countries in 2017
Figure United States Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Peptide Therapeutics Sales and Growth Rate (2013-2018)
Table North America Peptide Therapeutics Sales by Manufacturer (2016-2017)
Figure North America Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure North America Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table North America Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Figure North America Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure North America Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table North America Peptide Therapeutics Sales by Type (2013-2018)
Table North America Peptide Therapeutics Sales Share by Type (2013-2018)
Table North America Peptide Therapeutics Revenue by Type (2013-2018)
Table North America Peptide Therapeutics Revenue Share by Type (2013-2018)
Table North America Peptide Therapeutics Sales by Application (2013-2018)
Table North America Peptide Therapeutics Sales Share by Application (2013-2018)
Table North America Peptide Therapeutics Revenue by Application (2013-2018)
Table North America Peptide Therapeutics Revenue Share by Application (2013-2018)
Figure Europe Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Peptide Therapeutics Sales by Countries (2013-2018)
Table Europe Peptide Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Peptide Therapeutics Revenue by Countries (2013-2018)
Figure Europe Peptide Therapeutics Revenue Market Share by Countries in 2016
Figure Europe Peptide Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure France Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Peptide Therapeutics Sales and Growth Rate (2013-2018)
Table Europe Peptide Therapeutics Sales by Manufacturer (2016-2017)
Figure Europe Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure Europe Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table Europe Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Figure Europe Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Europe Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table Europe Peptide Therapeutics Sales by Type (2013-2018)
Table Europe Peptide Therapeutics Sales Share by Type (2013-2018)
Table Europe Peptide Therapeutics Revenue by Type (2013-2018)
Table Europe Peptide Therapeutics Revenue Share by Type (2013-2018)
Table Europe Peptide Therapeutics Sales by Application (2013-2018)
Table Europe Peptide Therapeutics Sales Share by Application (2013-2018)
Table Europe Peptide Therapeutics Revenue by Application (2013-2018)
Table Europe Peptide Therapeutics Revenue Share by Application (2013-2018)
Figure Asia-Pacific Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Peptide Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Peptide Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Peptide Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Peptide Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific Peptide Therapeutics Revenue Market Share by Countries 2017
Figure China Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure India Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Peptide Therapeutics Sales and Growth Rate (2013-2018)
Table Asia-Pacific Peptide Therapeutics Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Peptide Therapeutics Sales by Type (2013-2018)
Table Asia-Pacific Peptide Therapeutics Sales Share by Type (2013-2018)
Table Asia-Pacific Peptide Therapeutics Revenue by Type (2013-2018)
Table Asia-Pacific Peptide Therapeutics Revenue Share by Type (2013-2018)
Table Asia-Pacific Peptide Therapeutics Sales by Application (2013-2018)
Table Asia-Pacific Peptide Therapeutics Sales Share by Application (2013-2018)
Table Asia-Pacific Peptide Therapeutics Revenue by Application (2013-2018)
Table Asia-Pacific Peptide Therapeutics Revenue Share by Application (2013-2018)
Figure South America Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Peptide Therapeutics Sales by Countries (2013-2018)
Table South America Peptide Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Peptide Therapeutics Sales Market Share by Countries in 2017
Table South America Peptide Therapeutics Revenue by Countries (2013-2018)
Table South America Peptide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Peptide Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Peptide Therapeutics Sales and Growth Rate (2013-2018)
Table South America Peptide Therapeutics Sales by Manufacturer (2016-2017)
Figure South America Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure South America Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table South America Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Figure South America Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure South America Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table South America Peptide Therapeutics Sales by Type (2013-2018)
Table South America Peptide Therapeutics Sales Share by Type (2013-2018)
Table South America Peptide Therapeutics Revenue by Type (2013-2018)
Table South America Peptide Therapeutics Revenue Share by Type (2013-2018)
Table South America Peptide Therapeutics Sales by Application (2013-2018)
Table South America Peptide Therapeutics Sales Share by Application (2013-2018)
Table South America Peptide Therapeutics Revenue by Application (2013-2018)
Table South America Peptide Therapeutics Revenue Share by Application (2013-2018)
Figure Middle East and Africa Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Peptide Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Peptide Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Peptide Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Peptide Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Peptide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peptide Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Peptide Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Peptide Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Peptide Therapeutics Sales and Growth Rate (2013-2018)
Table Middle East and Africa Peptide Therapeutics Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Peptide Therapeutics Sales by Type (2013-2018)
Table Middle East and Africa Peptide Therapeutics Sales Share by Type (2013-2018)
Table Middle East and Africa Peptide Therapeutics Revenue by Type (2013-2018)
Table Middle East and Africa Peptide Therapeutics Revenue Share by Type (2013-2018)
Table Middle East and Africa Peptide Therapeutics Sales by Application (2013-2018)
Table Middle East and Africa Peptide Therapeutics Sales Share by Application (2013-2018)
Table Middle East and Africa Peptide Therapeutics Revenue by Application (2013-2018)
Table Middle East and Africa Peptide Therapeutics Revenue Share by Application (2013-2018)
Table Global Peptide Therapeutics Sales by Type (2013-2018)
Table Global Peptide Therapeutics Sales Share by Type (2013-2018)
Table Global Peptide Therapeutics Revenue by Type (2013-2018)
Table Global Peptide Therapeutics Revenue Share by Type (2013-2018)
Figure Global Injection Sales Growth (2013-2018)
Figure Global Injection Price (2013-2018)
Figure Global Oral Sales Growth (2013-2018)
Figure Global Oral Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Peptide Therapeutics Sales by Application (2013-2018)
Table Global Peptide Therapeutics Sales Share by Application (2013-2018)
Figure Global Cancer Sales Growth (2013-2018)
Figure Global Metabolic Disorders Sales Growth (2013-2018)
Figure Global Central Nervous System Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Peptide Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Peptide Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Peptide Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Peptide Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Peptide Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Peptide Therapeutics Market Forecast (2018-2023)
Figure South America Sales Peptide Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Peptide Therapeutics Market Forecast (2018-2023)
Table Global Peptide Therapeutics Sales Forecast by Type (2018-2023)
Table Global Peptide Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Peptide Therapeutics Sales Forecast by Application (2018-2023)
Table Global Peptide Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List